营养和非营养甜味剂对的作用:系统性审查
Trang Thi Minh Nguyen1, Eun-Ji Yi1, Xiangji Jin2
1Graduate School of Biotechnology, Kyung Hee University, 1732 Deogyeong-daero, Giheung-gu, Yongin-si 17104, Republic of Korea.
Fitoterapia
|December 9, 2025
概括
诸如曼尼托尔和西利托尔之类的甜味剂可以通过减少炎症和对抗Cutibacterium acnes来帮助控制. 将它们与其他化合物结合起来可以增强这些效果,提供新的治疗策略.
科学领域:
- 皮肤病学和微生物学
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种常见的炎症性皮肤疾病,受脂,激素和细菌的影响.
- 饮食因素,包括甜味剂,可能会影响的发展和严重程度.
- 了解甜味剂对病原体的作用对于有效管理至关重要.
研究的目的:
- 系统地审查营养和非营养甜味剂对相关标记物的影响.
- 研究甜味剂对Cutibacterium acnes (C. acnes) 活动和炎症的影响.
- 探索甜味剂与生物活性化合物的潜在协同作用.
主要方法:
- 对调查甜味剂和的研究进行系统文献综述.
- 对脂质产生,炎症和C. acnes的影响分析.
- 对甜味剂与其他活性成分的组合进行评估.
主要成果:
- 非营养甜味剂 (曼尼托尔,西利托尔) 在调节和抑制C. acnes方面表现有前途.
- 像曼尼托尔与巴库基醇或西利托尔与酸这样的组合可以增强抗炎和抗菌作用.
- 营养甜味剂 (葡萄糖) 可能会增加C. acnes对抗生素的敏感性.
结论:
- 甜味剂可以调节病原体,影响C. acnes和炎症.
- 甜味剂的战略性使用,单独或组合,为治疗提供了一个补充的方法.
- 甜味剂正在成为皮肤健康和管理的功能调节剂.
相关概念视频
Glucose Transporters
27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
Oral Hypoglycemic Agents: Sulfonylureas
728
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
728
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
509
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
509
Glucose Absorption Into the Small Intestine
34.7K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
34.7K
Surface Membrane Barriers
2.5K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617


